Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
Financial Results:
Camlin Fine Sciences Ltd reported Revenues for Q1FY25 of ₹396.00 Crores down from ₹420.00 Crore year on year, a fall of 5.71%.
Total Expenses for Q1FY25 of ₹421.00 Crores up from ₹410.00 Crores year on year, a rise of 2.68%.
Consolidated Net Profit of -₹35.00 Crores from ₹12.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹2.03, from ₹0.93 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.